103 related articles for article (PubMed ID: 1331933)
1. Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome.
Baird PN; Groves N; Haber DA; Housman DE; Cowell JK
Oncogene; 1992 Nov; 7(11):2141-9. PubMed ID: 1331933
[TBL] [Abstract][Full Text] [Related]
2. Exclusion of the Wilms tumour gene (WT1) promoter as a site of frequent mutation in Wilms tumour.
Grubb GR; Yun K; Reeve AE; Eccles MR
Oncogene; 1995 Apr; 10(8):1677-81. PubMed ID: 7731725
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity for chromosome region 11p15 in Wilms' tumours is not related to HRAS gene transforming mutations.
Baird P; Wadey R; Cowell J
Oncogene; 1991 Jul; 6(7):1147-9. PubMed ID: 1861864
[TBL] [Abstract][Full Text] [Related]
4. Genotype/phenotype correlations in Wilms' tumor.
Huff V
Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067
[TBL] [Abstract][Full Text] [Related]
5. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour.
Pelletier J; Bruening W; Li FP; Haber DA; Glaser T; Housman DE
Nature; 1991 Oct; 353(6343):431-4. PubMed ID: 1654525
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient.
Brown KW; Watson JE; Poirier V; Mott MG; Berry PJ; Maitland NJ
Oncogene; 1992 Apr; 7(4):763-8. PubMed ID: 1314370
[TBL] [Abstract][Full Text] [Related]
7. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.
Cowell JK; Groves N; Baird P
Br J Cancer; 1993 Jun; 67(6):1259-61. PubMed ID: 8390282
[TBL] [Abstract][Full Text] [Related]
9. The third zinc finger of the WT1 gene is mutated in Wilms' tumour but not in a broad range of other urogenital tumours.
Quek HH; Chow VT; Tock EP
Anticancer Res; 1993; 13(5A):1575-80. PubMed ID: 8239537
[TBL] [Abstract][Full Text] [Related]
10. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
Park S; Tomlinson G; Nisen P; Haber DA
Cancer Res; 1993 Oct; 53(20):4757-60. PubMed ID: 8402654
[TBL] [Abstract][Full Text] [Related]
11. Structural rearrangements of the WT1 gene in Wilms' tumour cells.
Cowell JK; Wadey RB; Haber DA; Call KM; Housman DE; Pritchard J
Oncogene; 1991 Apr; 6(4):595-9. PubMed ID: 1851548
[TBL] [Abstract][Full Text] [Related]
12. Genomic imprinting at the WT1 gene involves a novel coding transcript (AWT1) that shows deregulation in Wilms' tumours.
Dallosso AR; Hancock AL; Brown KW; Williams AC; Jackson S; Malik K
Hum Mol Genet; 2004 Feb; 13(4):405-15. PubMed ID: 14681303
[TBL] [Abstract][Full Text] [Related]
13. Homozygous intragenic deletion in the WT1 gene in a sporadic Wilms' tumour associated with high levels of expression of a truncated transcript.
Algar EM; Kenney MT; Simms LA; Smith SI; Kida Y; Smith PJ
Hum Mutat; 1995; 5(3):221-7. PubMed ID: 7599632
[TBL] [Abstract][Full Text] [Related]
14. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.
Pritchard-Jones K; Fleming S
Oncogene; 1991 Dec; 6(12):2211-20. PubMed ID: 1722569
[TBL] [Abstract][Full Text] [Related]
15. The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms' tumor.
Barbosa AS; Hadjiathanasiou CG; Theodoridis C; Papathanasiou A; Tar A; Merksz M; Györvári B; Sultan C; Dumas R; Jaubert F; Niaudet P; Moreira-Filho CA; Cotinot C; Fellous M
Hum Mutat; 1999; 13(2):146-53. PubMed ID: 10094551
[TBL] [Abstract][Full Text] [Related]
16. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
[TBL] [Abstract][Full Text] [Related]
17. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping.
Gessler M; Poustka A; Cavenee W; Neve RL; Orkin SH; Bruns GA
Nature; 1990 Feb; 343(6260):774-8. PubMed ID: 2154702
[TBL] [Abstract][Full Text] [Related]
18. Lack of linkage of familial Wilms' tumour to chromosomal band 11p13.
Huff V; Compton DA; Chao LY; Strong LC; Geiser CF; Saunders GF
Nature; 1988 Nov; 336(6197):377-8. PubMed ID: 2848200
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
[TBL] [Abstract][Full Text] [Related]
20. Mutations of p53 in Wilms' tumors.
Takeuchi S; Bartram CR; Ludwig R; Royer-Pokora B; Schneider S; Imamura J; Koeffler HP
Mod Pathol; 1995 Jun; 8(5):483-7. PubMed ID: 7675765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
